Skip to main content

Table 2 Acute adverse events of IMRT with target volume determined by PET-CT

From: Efficacy and safety of FDG-PET for determining target volume during intensity-modulated radiotherapy for head and neck cancer involving the oral level

Acute adverse events

Grade 2 (%)

Grade 3 (%)

Grade 4 (%)

Dermatitis

33

22

0

Mucositis

66

22

0

Dysphagia

0

22

0

Dry mouth

44

0

0

Taste disorder

44

0

0